Cargando…

Brain imaging biomarkers for the Alzheimer’s Prevention Initiative

Detalles Bibliográficos
Autores principales:	Chen, Kewei, Fleisher, Adam S, Ayutyanont, Napatkamon, Langbaum, Jessica B, Caselli, Richard, Quiroz, Yakeel T, Lopera, Francisco, Tariot, Pierre N, Reiman, Eric M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479859/ http://dx.doi.org/10.1186/1479-5876-10-S2-A28

Ejemplares similares

Association between an Alzheimer’s Disease-Related Index and APOE ε4 Gene Dose
por: Schraml, Frank, et al.
Publicado: (2013)

Adherence/Retention Alzheimer's Prevention Initiative Colombia Plan
por: Rios-Romenets, Silvia, et al.
Publicado: (2018)

Sex Differences in Cognitive Abilities Among Children With the Autosomal Dominant Alzheimer Disease Presenilin 1 E280A Variant From a Colombian Cohort
por: Fox-Fuller, Joshua T., et al.
Publicado: (2021)

Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial
por: Rios‐Romenets, Silvia, et al.
Publicado: (2020)

The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
por: Langbaum, Jessica B., et al.
Publicado: (2020)

Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials
por: Langlois, Carolyn M., et al.
Publicado: (2019)

The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort
por: Tariot, Pierre N., et al.
Publicado: (2018)

The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease
por: Lopez Lopez, Cristina, et al.
Publicado: (2019)

White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer’s disease that emerge prior to dementia
por: Schoemaker, Dorothee, et al.
Publicado: (2022)

Clinical and multimodal biomarker correlates of ADNI neuropathological findings
por: Toledo, Jon B, et al.
Publicado: (2013)

Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer’s Disease
por: Penny, Will, et al.
Publicado: (2018)

Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease
por: Hanseeuw, Bernard J., et al.
Publicado: (2019)

PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer’s disease-causing Presenilin-1 E280A mutation carriers
por: Ghisays, Valentina, et al.
Publicado: (2021)

Spectral Analysis of EEG in Familial Alzheimer's Disease with E280A Presenilin-1 Mutation Gene
por: Rodriguez, Rene, et al.
Publicado: (2014)

Rationale for the selection of dual primary endpoints in prevention studies of cognitively unimpaired individuals at genetic risk for developing symptoms of Alzheimer’s disease
por: Caputo, Angelika, et al.
Publicado: (2023)

Pressure Injury as Insidious Comorbidity in Ventilator-Dependent Respiratory Failure (VDRF) Secondary to COVID-19: A Case Report
por: Rodriguez, Carlos, et al.
Publicado: (2022)

The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer’s disease
por: Vila-Castelar, Clara, et al.
Publicado: (2020)

Does exposure to a seclusion and restraint event during clerkship influence medical student's attitudes toward psychiatry?
por: Sood, Shabnam, et al.
Publicado: (2017)

805. Did Mask Mandates have an Affect on Pulmonary Mycoses? Trends of Coccidioidomycosis Incidence during COVID-19 Pandemic Era in California and Texas
por: Abeydeera, Nirusha, et al.
Publicado: (2023)

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease
por: Norton, Daniel J., et al.
Publicado: (2020)

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts
por: Qian, Jing, et al.
Publicado: (2017)

1324. Impact of Implementation of CSF PCR Panel in Patients with Meningitis
por: Hsu, Eric, et al.
Publicado: (2023)

A Spanish Neuropsychological Battery Discriminates Between the Behavioral Variant of Frontotemporal Dementia and Primary Progressive Aphasia in a Colombian Sample
por: Velilla, Lina, et al.
Publicado: (2021)

OR30-2 Efficacy and Safety of Percutaneous Ethanol Ablation of Parathyroid Adenoma
por: Nakhle, Samer, et al.
Publicado: (2019)

338. Analysis of Etiologies of Aseptic Meningitis within a Nation-Wide Hospital Network
por: Aravagiri, Arunmozhi S, et al.
Publicado: (2020)

COVID-19 related disruptions to medical education and perceived clinical capability of new resident physicians: a nationwide study of over 1200 first-year residents
por: Guldner, Gregory, et al.
Publicado: (2022)

COVID-19 vaccination decreased COVID-19 hospital length of stay, in-hospital death, and increased home discharge
por: Lee, Se Won, et al.
Publicado: (2023)

6 CIRRHOSIS IS ASSOCIATED WITH SIGNIFICANTLY WORSENED CLINICAL OUTCOMES OF COVID-19 INFECTION IN A RETROSPECTIVE ANALYSIS OF 23,474 PATIENTS ACROSS 143 HOSPITALS
por: Hwang, Andrew W., et al.
Publicado: (2021)

Fr495 INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH SIGNIFICANTLY WORSENED CLINICAL OUTCOMES OF COVID-19 INFECTION IN A RETROSPECTIVE ANALYSIS OF 78,756 PATIENTS ACROSS 143 HOSPITALS
por: Zackria, Rasiq, et al.
Publicado: (2021)

Trajectory of Unawareness of Memory Decline in Individuals With Autosomal Dominant Alzheimer Disease
por: Vannini, Patrizia, et al.
Publicado: (2020)

1185. Association Between Blood Product Transfusion and Development of Hospital Acquired Infections or Mortality in Patients Admitted to the Hospital Wards. A Retrospective Case-Control Study
por: Aravagiri, Arunmozhi S, et al.
Publicado: (2020)

788 INCREASE IN ALCOHOLIC HEPATITIS CASES DURING COVID PANDEMIC IN THE US
por: Nair, Geethu G., et al.
Publicado: (2021)

Resistance to autosomal dominant Alzheimer’s in an APOE3-Christchurch homozygote: a case report
por: Arboleda-Velasquez, Joseph F., et al.
Publicado: (2019)

Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study
por: Sanchez, Justin S., et al.
Publicado: (2021)

Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer’s disease
por: Guzmán-Vélez, Edmarie, et al.
Publicado: (2022)

Brain imaging measurements of fibrillar amyloid‐β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele
por: Ghisays, Valentina, et al.
Publicado: (2020)

Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona
por: Tan, Susanna, et al.
Publicado: (2017)

Impact of the COVID-19 Pandemic on Trauma Encounters
por: Sheets, Nicholas W., et al.
Publicado: (2023)

Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease
por: Littau, Jessica Lisa, et al.
Publicado: (2022)

Cognitive performance in asymptomatic carriers of mutations R1031C and R141C in CADASIL
por: Zuluaga-Castaño, Yesica, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pagoa1ie7gvuvcnr12kfnhbk26